Alzheimer Drugs: How Donanemab Compares to Lecanemab
Drug developers are making progress with treatments for Alzheimer’s disease, one of the leading causes of dementia.Just five months after the US Food and Drug Administration (FDA) granted “accelerated” approval for a drug to treat Alzheimer’s disease,…